Stanley Lau
Direktor/Vorstandsmitglied bei SOLASIA PHARMA K.K.
Profil
Stanley is a Special Advisor to Pappas Capital.
He is also CEO of TaiLai Biosciences, a Chinese biotechnology company providing a new generation of biopsy products and services based on its proprietary biomultiomics technology.
With over 40 years of business and healthcare experience, Stanley has served in a variety of senior roles in China and internationally with organizations including MSD, Baxter, Schering-Plough, China Biologic Products, Amsino Medical Group.
He currently serves as Non-Executive Chairman of the Board of Gland Pharma and as an independent director of Solasia Pharma K.K.
Aktive Positionen von Stanley Lau
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLASIA PHARMA K.K. | Direktor/Vorstandsmitglied | - |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Berater | - |
Ehemalige bekannte Positionen von Stanley Lau
| Unternehmen | Position | Ende |
|---|---|---|
| GLAND PHARMA LIMITED | Vorsitzender | - |
Ausbildung von Stanley Lau
| University of London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GLAND PHARMA LIMITED | Health Technology |
| SOLASIA PHARMA K.K. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
